Advertisement
News
Advertisement

AASLD Curriculum & Training (ACT) Launches With New Interactive HCV Education

Sat, 11/10/2012 - 9:06am
Bio-Medicine.Org

BOSTON, Nov. 10, 2012 /PRNewswire/ -- The American Association for the Study of Liver Diseases (www.aasld.org) today announced a new initiative to provide ongoing education and training to healthcare professionals treating liver diseases. AASLD Curriculum & Training (ACT) will deliver reliable information and instruction for the treatment of patients with a variety of liver diseases including viral hepatitis.

The first program to be released, ACT on HCV, A Practical Introduction to Treating HCV, includes five interactive modules with case-based discussions and real-life clinical scenarios. This program is designed to increase the competence of healthcare professionals who are new to providing care for patients with HCV.

"ACT on HCV is exactly what it sounds like! As the numbers of HCV-infected patients presenting in a range of clinical settings continues to grow, we need to be able to provide all of our healthcare professionals - who are not liver specialists - with the tools necessary for them to be able to manage and support their patients," said Sue Currie, AASLD Hepatology Associates Committee Task Force Chair. "AASLD is helping to address this need in a unique and innovative way, which ultimately benefits patients affected with HCV, but also the healthcare professionals in the field."

The CME/CE-certified modules are 30 to 45 minutes in length and are supplemented with pre- and post-test questions which help identify key topics and guide the learner to specific sections for study. Module topics include:

  • HCV Overview
  • HCV Genotyping and Predictors of Response
  • Patient Selection
  • Initiating HCV Treatment: The First 8 Weeks
  • Managing Side Effects of Therapy

"The modules in this program are designed to fit into the busy schedules of active healthcare providers," said HoChong Gilles, RN, M
'/>"/>

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading